NIDA-funded trial

In view of the most recent Congressional advancement in psychedelics regulation, a bipartisan bill creating a $75 million research grant program for the potential treatment of mental health conditions in active duty military members, Republican lawmakers and military veterans joined a press...

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) shared its condensed interim (unaudited) financial results for three months ended March 31, 2023. First quarter numbers:  Cash and cash equivalents of $7.650 (CA$10,291) as of March 31, 2023, compared to $8.199 garnered...